HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A portable visual acuity device used in diabetic retinal screening.

AbstractPURPOSE:
To correlate visual acuity measured with the Optec 800 to the gold-standard Early Treatment Diabetic Retinopathy Study (ETDRS) chart.
DESIGN:
Prospective, cross-sectional study.
METHODS:
Forty patients of the Vanderbilt Eye Institute agreed to undergo visual acuity testing. Five patients were excluded because of enucleation or functional blindness of one or both eyes. Two patients were excluded because of poor cooperation during testing. Patients were randomized to one of the two methods and participated in visual acuity testing in a forced-choice manner. The sequence was repeated with the alternate instrument. A total-correct score was calculated for each data set.
RESULTS:
There was no statistically significant difference in scores between the two methods (P(1) = .153, P(2) = .307.) Other factors such as gender, age, and instrument testing order did not affect performance. Age was inversely correlated with total correct score.
CONCLUSIONS:
In this small cohort, the Optec 800 (Chicago, Illinois, USA) and the ETDRS chart recorded similar visual acuity measurements.
AuthorsLori Ann F Kehler, K Bradley Kehler, Lawrence M Merin, James C Tsai
JournalAmerican journal of ophthalmology (Am J Ophthalmol) Vol. 143 Issue 3 Pg. 514-5 (Mar 2007) ISSN: 0002-9394 [Print] United States
PMID17317400 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Cross-Over Studies
  • Diabetic Retinopathy (diagnosis, physiopathology)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Sensitivity and Specificity
  • Vision Disorders (diagnosis, physiopathology)
  • Vision Screening (instrumentation)
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: